Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by GeriPal, Alex Smith, and Eric Widera. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by GeriPal, Alex Smith, and Eric Widera or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

How to Make an Alzheimer's Diagnosis in Primary Care: A Podcast with Nathaniel Chin

47:52
 
Share
 

Manage episode 465212116 series 1279663
Content provided by GeriPal, Alex Smith, and Eric Widera. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by GeriPal, Alex Smith, and Eric Widera or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Things are changing quickly in the Alzheimer’s space. We now have biomarkers that can reasonably approximate the degree of amyloid build-up in the brain with a simple blood test. We have two new FDA-approved medications that reduce that amyloid buildup and modestly slow down the progression of the disease. So, the question becomes, what, if anything, should we do differently in the primary care setting to diagnose the disease?

On today’s podcast, we’ve invited Nathaniel Chin back to the GeriPal podcast to talk about what primary care needs to manage this new world of Alzheimer’s disease effectively. Nate is a geriatrician and clinician-scientist at the University of Wisconsin, as well as the host of the Wisconsin ADRC's podcast, "Dementia Matters." In each bi-weekly episode, he interviews Alzheimer's disease experts about research advances and caregiver strategies. Nate also wrote a NEJM piece last year on “Alzheimer’s Disease, Biomarkers, and mAbs — What Does Primary Care Need?

We address the following questions with Nate:

  • Has anything changed for the primary care doctor when diagnosing Alzheimer’s? How should we screen for cognitive impairment?

  • Does a good history matter anymore?

  • What’s the role of assessing function?

  • What do we do with those who have only subjective cognitive complaints?

  • Can’t we skip all this and just send some blood-based biomarkers?

  • What is the role of the amyloid antibody treatments?

Lastly, take a look at the following if you want to take a deeper dive into some of the other articles and podcasts we discuss:

  continue reading

361 episodes

Artwork
iconShare
 
Manage episode 465212116 series 1279663
Content provided by GeriPal, Alex Smith, and Eric Widera. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by GeriPal, Alex Smith, and Eric Widera or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Things are changing quickly in the Alzheimer’s space. We now have biomarkers that can reasonably approximate the degree of amyloid build-up in the brain with a simple blood test. We have two new FDA-approved medications that reduce that amyloid buildup and modestly slow down the progression of the disease. So, the question becomes, what, if anything, should we do differently in the primary care setting to diagnose the disease?

On today’s podcast, we’ve invited Nathaniel Chin back to the GeriPal podcast to talk about what primary care needs to manage this new world of Alzheimer’s disease effectively. Nate is a geriatrician and clinician-scientist at the University of Wisconsin, as well as the host of the Wisconsin ADRC's podcast, "Dementia Matters." In each bi-weekly episode, he interviews Alzheimer's disease experts about research advances and caregiver strategies. Nate also wrote a NEJM piece last year on “Alzheimer’s Disease, Biomarkers, and mAbs — What Does Primary Care Need?

We address the following questions with Nate:

  • Has anything changed for the primary care doctor when diagnosing Alzheimer’s? How should we screen for cognitive impairment?

  • Does a good history matter anymore?

  • What’s the role of assessing function?

  • What do we do with those who have only subjective cognitive complaints?

  • Can’t we skip all this and just send some blood-based biomarkers?

  • What is the role of the amyloid antibody treatments?

Lastly, take a look at the following if you want to take a deeper dive into some of the other articles and podcasts we discuss:

  continue reading

361 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play